Global Financial Private Client’s ResMed RMD Stock Holding History

Global Financial Private Client’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-33	Closed	-$7.39K	–	1295
2025 Q1	$7.39K	Buy	33 +6	+22%	+$1.4K	﹤0.01%	634
2024 Q4	$6.17K	Buy	27 +3	+13%	+$722	﹤0.01%	620
2024 Q3	$5.86K	Buy	24 +19	+380%	+$4.25K	﹤0.01%	622
2024 Q2	$957	Hold	5	–	–	﹤0.01%	622
2024 Q1	$947	Hold	5	–	–	﹤0.01%	640
2023 Q4	$860	Hold	5	–	–	﹤0.01%	634
2023 Q3	$729	Hold	5	–	–	﹤0.01%	628
2023 Q2	$1.07K	Hold	5	–	–	﹤0.01%	609
2023 Q1	$1.1K	Hold	5	–	–	﹤0.01%	615
2022 Q4	$1.04K	Buy	+5	New	+$1.1K	﹤0.01%	609

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Global Financial Private Client's RMD Position: Q2 2025 in Review

Global Financial Private Client sold out of ResMed (RMD) in Q2 2025, closing a stake of 33 shares — an estimated $7.39K sold.

Global Financial Private Client first reported a position in RMD in Q4 2022 and held it in 10 quarters. The position peaked at $7.39K in Q1 2025. 919 funds tracked by Wall St. Rank hold RMD as of Q2 2025.

Global Financial Private Client reported no remaining ResMed position as of Q2 2025 after selling out during the quarter.
Global Financial Private Client sold 33 ResMed shares in Q2 2025, an estimated $7.39K.
Global Financial Private Client first reported a position in ResMed in Q4 2022 and held it in 10 quarters.
Global Financial Private Client's ResMed position peaked at $7.39K in Q1 2025.
919 funds tracked by Wall St. Rank held ResMed as of Q2 2025.

Based on Global Financial Private Client's 13F filing for Q2 2025, filed 10 Jul 2025.